DailySand tracks DEA across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where DEA appears in today's cross-sector intelligence briefing.
2 items across 5 digests
The U.S. Drug Enforcement Administration will hold a June 29 administrative hearing to evaluate broader cannabis rescheduling beyond the Schedule III medical classification finalized earlier. Resolution impacts federal-state regulatory alignment and capital availability for cannabis-adjacent agricultural and processing infrastructure.
Read original →The U.S. Drug Enforcement Administration is holding an administrative hearing on June 29 to consider rescheduling cannabis, building on an earlier final order that moved state-licensed medical cannabis to Schedule III. This regulatory shift could unlock a broader adult-use market and attract institutional capital to cannabis-related sectors.
Read original →
DailySand